Research Progress of Circulating Tumor DNA in Non-small Cell Lung Cancer.
10.3779/j.issn.1009-3419.2022.102.35
- Author:
Siyu LEI
1
;
Yan WANG
1
Author Information
1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Publication Type:Journal Article
- Keywords:
Circulating tumor DNA;
Lung neoplasms;
Research progress
- MeSH:
Biomarkers, Tumor/genetics*;
Carcinoma, Non-Small-Cell Lung/genetics*;
Circulating Tumor DNA/genetics*;
Humans;
Lung Neoplasms/genetics*;
Mutation;
Neoplasm Recurrence, Local
- From:
Chinese Journal of Lung Cancer
2022;25(9):665-670
- CountryChina
- Language:Chinese
-
Abstract:
With the concept of "Precision Medicine" in malignant tumors popularized, many substances carrying valuable clinical information have emerged in the process of exploring the occurrence and development of tumors from a microscopic perspective. Circulating tumor DNA (ctDNA) is one of them. In various clinical stages of cancer, ctDNA exhibits rich diagnostic values including demonstrating the efficacy of treatment, predicting prognosis, and monitoring disease recurrence. This article mainly describes the application and research progress of ctDNA in different stages of clinical diagnosis and treatment of non-small cell lung cancer .
.
